Bixiye
QP51-21 Commercial Pharmacy Benefit Update – Revised Drug-Related Prior Authorization (PA) Requirement Notification – Effective July 25, 2021
Taariikhda wax ku ool ah ee barnaamijka: Jun 09, 2021
Dukumentiyadda & Foomamka Natiijooyinka
Soo bandhiga 2141 - 2150 ee natiijooyinka 3167
Bixiye
QP47-21 Audio-Only Telehealth Visits do not Meet Requirements for Risk Adjustment Face-to-Face Requirement
Taariikhda wax ku ool ah ee barnaamijka: Jun 09, 2021
Bixiye
QP49-21 Update for New to Market Medical Drugs: Anifrolumab, Teplizumab, Donislecel, and Difelikefalin
Taariikhda wax ku ool ah ee barnaamijka: Jun 09, 2021
Bixiye
QP48-21 Learn to Live – An Online Behavioral Health Resource for Select Blue Cross and Blue Shield of Minnesota Health Plan Members
Taariikhda wax ku ool ah ee barnaamijka: Jun 09, 2021
Bixiye
P35-21 eviCore Healthcare Specialty Utilization Management (UM) Program – Medical Oncology Drug Prior Authorization Updates for Fully Insured Commercial and Medicare Advantage Subscribers
Taariikhda wax ku ool ah ee barnaamijka: Jun 01, 2021
Bixiye
P33-21 Change to Medical Review Process for Outpatient Therapies Services
Taariikhda wax ku ool ah ee barnaamijka: Jun 01, 2021
Bixiye
P36-21 Site of Service for Selected Outpatient Procedures: XI-03 Medical Policy Update
Taariikhda wax ku ool ah ee barnaamijka: Jun 01, 2021
Bixiye
P34-21 New Medical, Medical Drug and Behavioral Health Policy Management Updates—Effective August 2, 2021
Taariikhda wax ku ool ah ee barnaamijka: Jun 01, 2021
Bixiye
P3R1-21 Update: eviCore Healthcare Specialty Utilization Management (UM) Program – Medical Oncology Drug Prior Authorization Updates for Fully Insured Commercial and Medicare Advantage Subscribers
Taariikhda wax ku ool ah ee barnaamijka: Jun 01, 2021
Bixiye
2021 June Bulletins
Taariikhda wax ku ool ah ee barnaamijka: Jun 01, 2021